Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
20.88
-0.26 (-1.23%)
At close: Mar 9, 2026, 4:00 PM EDT
20.88
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Tandem Diabetes Care Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,015 | 940.2 | 747.72 | 801.22 | 702.8 | Upgrade
|
| Revenue Growth (YoY) | 7.93% | 25.74% | -6.68% | 14.00% | 40.89% | Upgrade
|
| Cost of Revenue | 468.72 | 450.63 | 380.03 | 388.23 | 326.58 | Upgrade
|
| Gross Profit | 546.01 | 489.57 | 367.69 | 412.99 | 376.22 | Upgrade
|
| Selling, General & Admin | 434.13 | 389.82 | 338.4 | 335.68 | 261.51 | Upgrade
|
| Research & Development | 190 | 198.88 | 169.67 | 139.11 | 92.05 | Upgrade
|
| Operating Expenses | 624.14 | 588.7 | 508.07 | 474.8 | 353.56 | Upgrade
|
| Operating Income | -78.12 | -99.13 | -140.38 | -61.81 | 22.65 | Upgrade
|
| Interest Expense | -7.91 | -7.42 | -9.88 | -6.21 | -6.04 | Upgrade
|
| Interest & Investment Income | 13.9 | 22.1 | 22.86 | 6.06 | 0.67 | Upgrade
|
| Earnings From Equity Investments | -14.19 | -2.05 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -5.4 | -2 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.59 | -0.11 | - | 0.15 | -1.39 | Upgrade
|
| EBT Excluding Unusual Items | -91.14 | -88.6 | -127.41 | -61.81 | 15.9 | Upgrade
|
| Merger & Restructuring Charges | -7.27 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -2 | - | - | - | Upgrade
|
| Asset Writedown | -6.7 | - | -14.1 | - | - | Upgrade
|
| Legal Settlements | -19.95 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | -1.27 | - | - | - | Upgrade
|
| Pretax Income | -200.27 | -91.87 | -220.25 | -92.85 | 15.9 | Upgrade
|
| Income Tax Expense | 4.44 | 4.16 | 2.36 | 1.74 | 0.34 | Upgrade
|
| Net Income | -204.71 | -96.03 | -222.61 | -94.59 | 15.57 | Upgrade
|
| Net Income to Common | -204.71 | -96.03 | -222.61 | -94.59 | 15.57 | Upgrade
|
| Shares Outstanding (Basic) | 67 | 65 | 65 | 64 | 63 | Upgrade
|
| Shares Outstanding (Diluted) | 67 | 65 | 65 | 64 | 64 | Upgrade
|
| Shares Change (YoY) | 2.80% | 0.74% | 1.28% | -0.32% | 5.51% | Upgrade
|
| EPS (Basic) | -3.04 | -1.47 | -3.43 | -1.47 | 0.25 | Upgrade
|
| EPS (Diluted) | -3.04 | -1.47 | -3.43 | -1.47 | 0.24 | Upgrade
|
| Free Cash Flow | -29.67 | 4.99 | -58.61 | 16.37 | 97.18 | Upgrade
|
| Free Cash Flow Per Share | -0.44 | 0.08 | -0.90 | 0.26 | 1.51 | Upgrade
|
| Gross Margin | 53.81% | 52.07% | 49.18% | 51.54% | 53.53% | Upgrade
|
| Operating Margin | -7.70% | -10.54% | -18.77% | -7.71% | 3.22% | Upgrade
|
| Profit Margin | -20.17% | -10.21% | -29.77% | -11.81% | 2.21% | Upgrade
|
| Free Cash Flow Margin | -2.92% | 0.53% | -7.84% | 2.04% | 13.83% | Upgrade
|
| EBITDA | -60.46 | -82.52 | -124.67 | -47.48 | 36.5 | Upgrade
|
| EBITDA Margin | -5.96% | -8.78% | -16.67% | -5.93% | 5.19% | Upgrade
|
| D&A For EBITDA | 17.67 | 16.61 | 15.72 | 14.33 | 13.85 | Upgrade
|
| EBIT | -78.12 | -99.13 | -140.38 | -61.81 | 22.65 | Upgrade
|
| EBIT Margin | -7.70% | -10.54% | -18.77% | -7.71% | 3.22% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 2.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.